Literature DB >> 8410496

Cathepsin D immunocytochemical assays in breast carcinomas: image analysis and correlation to prognostic factors.

C Charpin1, B Devictor, P Bonnier, L Andrac, M N Lavaut, C Allasia, L Piana.   

Abstract

Immunocytochemical assays of cathepsin D were assessed in a series of breast carcinomas (n = 257) using monoclonal M1G8 anti-total cathepsin D and the avidin-biotin-peroxidase complex. Cathepsin immunoreactivity was compared in frozen and paraffin sections. All tumours were anti-cathepsin-positive. Positive staining was observed in carcinoma and stromal cells and in the extracellular matrix. The amount of immunodetectable cathepsin in tissue was measured by computer-assisted image analysis (SAMBA 2005). Both the percentage of immunostained tumour surface and the mean optical densities were processed as continuous variables for statistical analysis and correlated with prognostic factors. It was shown that cathepsin D was independent of the tumour size, the lymph node status, hormone receptors, and pHER-2/neu overexpression. Cathepsin was significantly correlated with anti-EGFR (P = 0.012) and Ki67 (P = 0.002) immunoreactivity, tumour grade (P = 0.032), vascular invasion (P = 0.0081), proliferation index (P = 0.0045), and, to a lesser extent with AgNORs (P = 0.0504) and the degree of hyperploidy (P = 0.057). Tissue fixation and paraffin embedding significantly decreased cathepsin immunoreactivity. These results show that cathepsin D is not a totally independent prognostic factor in breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8410496     DOI: 10.1002/path.1711700410

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  7 in total

1.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

2.  Expressions of chromogranin A and cathepsin D in human primary hepatocellular carcinoma.

Authors:  Xiao-Feng Huang; Chun-Mei Wang; Xiao-Wen Dai; Zhen- Jiang Li; Bo-Rong Pan; Li-Bin Yu; Bin Qian; Li Fang
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Cathepsin D detected by automated and quantitative immunohistochemistry in breast carcinomas: correlation with overall and disease free survival.

Authors:  C Charpin; S Garcia; C Bouvier; F Martini; M Lavaut; C Allasia; P Bonnier; L Andrac
Journal:  J Clin Pathol       Date:  1997-07       Impact factor: 3.411

4.  Immunolocalization of cathepsin D in pneumocytes of normal human lung and in pulmonary fibrosis.

Authors:  M Kasper; P Lackie; M Haase; D Schuh; M Müller
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

5.  Proliferation Markers and EGF in ACTH-Secreting Adenomas and Carcinomas of the Pituitary.

Authors:  Dorothee Lubke; Wolfgang Saeger; Dieter K. Ludecke
Journal:  Endocr Pathol       Date:  1995       Impact factor: 3.943

6.  Automated and quantitative immunocytochemical assays of Bcl-2 protein in breast carcinomas.

Authors:  C Charpin; S Garcia; C Bouvier; B Devictor; L Andrac; M N Lavaut; C Allasia
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factors.

Authors:  T Jahkola; T Toivonen; K von Smitten; I Virtanen; V M Wasenius; C Blomqvist
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.